Showing results (381-390 of 1,014) with videos related to

Sort By:
Pageof 102
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1983
Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenololP N Leigh, D Jefferson, A Twomey, et al.
Acta Neurologica Scandinavica|November 11, 2009
Natural history, symptoms and treatment of the narcoleptic syndromeJ D Parkes, M Baraitser, C D Marsden, et al.
Biochemical Pharmacology|July 7, 1992
Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervationK L Thomas, S Rose, P Jenner, et al.
Neuroscience Letters|April 6, 1984
Functional increase in striatal dopaminergic activity following continuous long-term treatment with trifluoperazineR Kerwin, N M Rupniak, P Jenner, et al.
Clinical Neuropharmacology|January 1, 1984
A double-blind trial of clonazepam in benign essential tremorC Thompson, A Lang, J D Parkes, et al.
Psychopharmacology|January 1, 1991
Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulationP Collins, C L Broekkamp, P Jenner, et al.
Neuropharmacology|April 1, 1987
In vitro characterisation of dopamine receptors in the superior colliculus of the ratM E Weller, S Rose, P Jenner, et al.
Neurology|September 26, 2001
A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonusS J Frucht, E D Louis, C Chuang, et al.
Life Sciences|July 11, 1983
Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosineA Reches, M N Hassan, V R Jackson, et al.
Neurology|February 1, 1984
Pergolide therapy for Parkinson's disease: neurobehavioral changesY Stern, R Mayeux, J Ilson, et al.
Pageof 102